BioAge CEO talks NLRP3 and ‘pipeline in a pill’ ambitions Read more 

Chutes & Ladders—Former FDA leader takes new biotech Turn Read more 

Has Novartis’ T-Charge been overtaken by in vivo CAR-Ts? Execs argue there’s room for both Read more 

Max Eldridge

Max has more than ten years in Life Sciences recruitment, He collaborates with executives to foster growth in Pharma, Biotech, CRO, TechBio, and Medical Device sectors​

Go to Top